| scholarly article | Q13442814 |
| P2093 | author name string | Kashiwagi K | |
| Igarashi K | |||
| Takeda Y | |||
| Yamasaki S | |||
| Kurazono H | |||
| Cao C | |||
| P2860 | cites work | Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I | Q24651553 |
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with the hemolytic uremic syndrome | Q33396788 | ||
| Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. | Q34049372 | ||
| Improvement of the dideoxy chain termination method of DNA sequencing by use of deoxy-7-deazaguanosine triphosphate in place of dGTP | Q36090179 | ||
| Infection by verocytotoxin-producing Escherichia coli | Q36634680 | ||
| Importance of arginine at position 170 of the A subunit of Vero toxin 1 produced by enterohemorrhagic Escherichia coli for toxin activity. | Q38334562 | ||
| Vero toxins (Shiga-like toxins) produced by enterohemorrhagic Escherichia coli (verocytotoxin-producing E. coli). | Q40782927 | ||
| Immunization of pigs with a purified Shiga-like toxin II variant toxoid | Q43813100 | ||
| Specific detection of a verotoxin 2 variant, VT2vp1, by a bead-enzyme-linked immunosorbent assay. | Q54645163 | ||
| Characterization of non-toxic mutant toxins of Vero toxin 1 that were constructed by replacing amino acids in the A subunit. | Q54651945 | ||
| Reproduction of Edema Disease of Swine with Purified Shiga-like Toxin-II Variant | Q54703471 | ||
| Development of a highly sensitive bead-ELISA to detect bacterial protein toxins. | Q54755738 | ||
| Verotoxin production among porcine strains of Escherichia coli and its association with oedema disease. | Q54758286 | ||
| Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin. | Q54763750 | ||
| Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin. | Q54765418 | ||
| Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2) | Q57563891 | ||
| Escherichia colistrains isolated from pigs with edema disease produce a variant of Shiga-like toxin II | Q57563893 | ||
| P433 | issue | 6 | |
| P921 | main subject | Escherichia coli | Q25419 |
| P304 | page(s) | 441-447 | |
| P577 | publication date | 1994-01-01 | |
| P1433 | published in | Microbiology and Immunology | Q15767399 |
| P1476 | title | Construction of mutant genes for a non-toxic verotoxin 2 variant (VT2vp1) of Escherichia coli and characterization of purified mutant toxins. | |
| P478 | volume | 38 |
| Q40409371 | A newly discovered verotoxin variant, VT2g, produced by bovine verocytotoxigenic Escherichia coli. |
| Q37424949 | Conserved Arginines at the P-Protein Stalk Binding Site and the Active Site Are Critical for Ribosome Interactions of Shiga Toxins but Do Not Contribute to Differences in the Affinity of the A1 Subunits for the Ribosome |
| Q34663367 | Identification of amino acids critical for the cytotoxicity of Shiga toxin 1 and 2 in Saccharomyces cerevisiae |
| Q40350819 | Improved porcine model for Shiga toxin-producing Escherichia coli infection by deprivation of colostrum feeding in newborn piglets. |
| Q34002364 | Monoclonal antibody to Shiga toxin 2 which blocks receptor binding and neutralizes cytotoxicity |
| Q35012362 | Protection against Shiga toxin 1 challenge by immunization of mice with purified mutant Shiga toxin 1. |
| Q33883465 | Protective immunization of mice with an active-site mutant of subtilase cytotoxin of Shiga toxin-producing Escherichia coli |
| Q74320355 | Shiga-like toxin-VEGF fusion proteins are selectively cytotoxic to endothelial cells overexpressing VEGFR-2 |
| Q35068024 | Simple method for Shiga toxin 2e purification by affinity chromatography via binding to the divinyl sulfone group |
| Q54400239 | Towards an attenuated enterohemorrhagic Escherichia coli O157:H7 vaccine characterized by a deleted ler gene and containing apathogenic Shiga toxins. |
Search more.